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Tall Stature and Poor Breast Development after Estrogen 
Replacement in a Hypergonadotrophic Hypogonadic Patient 
with a 45,X/46,X,der(X) Karyotype with SHOX Gene Overdosage
ABSTRACT
SHOX is exclusively expressed in the developing distal limb bones of human 
embryos and in the fi rst and second pharyngeal arches. It works as a pro-
moter for linear growth and as a repressor of growth plate fusion. It was re-
ported, recently, that SHOX overdosage and gonadal estrogen defi ciency 
have led to tall stature due to continued growth. We report, in the present 
study, a female patient with 45,X/46,X, psu idic(X)(pter→q21::q21→pter) kary-
otype, tall stature, and hypergonadotrophic hypogonadism without Turner 
stigmas. She did not present breast development even after long term thera-
py with high estrogen doses. Fluorescence in situ hybridization depicted the 
presence of three copies of SHOX gene. Microsatellite studies showed pater-
nal origin of der(X). Further studies in similarly affected patients will clarify if 
the absence of breast development, despite previous high-dose estrogen 
treatment, is associated to triple copy of SHOX gene. (Arq Bras Endocrinol 
Metab 2008; 52/8:1282-1287)
Keywords: SHOX overdosage; Tall stature; Gonadal dysgenesis
RESUMO
Estatura Alta e Hipodesenvolvimento Mamário após Reposição Estrogênica 
em Paciente com Hipogonadismo Hipergonadotrófi co e Cariótipo 45,X/46,X, 
der(X) com Superdosagem do Gene SHOX.
O gene SHOX é expresso, exclusivamente, no primeiro e no segundo arcos 
faríngeos, assim como nas extremidades dos ossos dos membros em em-
briões humanos. SHOX normalmente atua como um promotor para o cresci-
mento linear e como um repressor do fechamento da placa de crescimento. 
Recentemente, foi descrito que o excesso da proteína SHOX associada à de-
fi ciência estrogênica gonadal leva à estatura alta devido ao contínuo cresci-
mento. Neste estudo descrevemos uma paciente do sexo feminino com 
cariótipo 45,X/46,X,psu idic(X)(pter→q21::q21→pter), estatura alta, hipogo-
nadismo hipergonadotrófi co e sem estigmas de Turner. A paciente não apre-
sentou desenvolvimento de mamas, mesmo depois do tratamento prolongado 
com altas doses de estrógenos. FISH evidenciou a presença de três cópias do 
SHOX. Estudo de microssatélites demonstrou a origem paterna do der(X). 
Estudos futuros em pacientes com semelhanças clínicas esclarecerão se a 
ausência de desenvolvimento de mamas, apesar do tratamento com altas 
doses de estrógenos, está associada à tripla cópia do SHOX. (Arq Bras Endo-
crinol Metab 2008; 52/8:1282-1287)
Descritores: Overdosagem de SHOX; Estatura alta; Defi ciência estrogênica 
gonadal 
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INTRODUCTION
At the end of short X and Y chromosome arms there is a common portion named short arm pseudoau-
tosomal region (PAR-1) spaning 2.6 Mb. PAR-1 esca-
pes from X inactivation process and recombines during 
male meiosis (1). Individuals with absence of this re-
gion present short stature which indicates that this re-
gion is related to growth (2,3). In 1997, two different 
groups described, simultaneously, a gene responsible 
for stature, SHOX (“Short Stature Homeobox-Contai-
ning Gene”) (2,3), located on the PAR-1. SHOX is 
composed by 7 exons with 40 kb in length (4), that 
encodes two different proteins, one with 292 and other 
with 225 amino acids due to an alternative splicing 
(2,3). It is exclusively expressed in the fi rst and second 
pharyngeal arches and in the developing distal limb bo-
nes of human embryos (5). SHOX normally functions 
as a promoter for linear growth and as a repressor for 
growth plate fusion and skeletal maturation (6). SHOX 
haploinsuffi ciency due to deletions or mutations leads 
to short stature and skeletal abnormalities such as in 
Turner syndrome, or Madelung deformity of the fore-
arm, such as in Léri-Weill dyscondrosteosis. 
Recently, patients with karyotype alterations invol-
ving sexual chromosomes resulting in SHOX overdosa-
ge were described in the literature (7-10). This fact 
associated to estrogen defi ciency owing to gonadal dys-
genesis seems to be the cause of excessive growth, espe-
cially in the distal limb bones, in the middle to late 
teenage females (7,10,11). 
In the present study, we report a 45,X/46,X,der(X) 
female patient with tall stature, low body mass index 
(BMI), no breast development or Turner’s stigmata 
and gonadal insuffi ciency in whom a SHOX gene over-
dosage was suspected.
METHODS
Cytogenetic Analysis
Chromosome metaphase spreads prepared from peri-
pheral blood lymphocyte cultures of the patient and 
her parents were analyzed by conventional staining, G 
and C banding techniques. The kit Vysis® Kallman Re-
gion Probe (Vysis Inc., Abbott Laboratories, Illinois, 
USA) and the biotinylated LLNOYCO3”M”34F5 cos-
mid containing exons III to VIb of SHOX gene were 
used for the FISH methodology. The analysis was per-
formed using the Karyotyping Software Macktype 
v.5.4.1 and Mackprobe v. 4.0 (Perceptive Scientifi c Ins-
truments Inc., UK) for FISH. 
Molecular Analysis
Genomic DNA was obtained from peripheral blood 
leukocytes using the Salting-Out technique (12). The 
microsatellite study was carried out using the panel for 
the X chromosome presented in the kit Linkage Map-
ping set v.2.5 MD10 (PE Applied Biosystems, The 
Perkin-Elmer Corporation, CA, USA). The PCR pro-
ducts were submitted to electrophoresis in the ABI 
PRISM 310 automatic sequencer (PE Applied Biosyste-
ms, The Perkin-Elmer Corporation, CA, USA) and the 
analysis was made by GeneScan software (PE Applied 
Biosystems, The Perkin-Elmer Corporation, CA, USA).
CASE REPORT
The present study was approved by the Ethics Com-
mittee of the Hospital das Clinicas, The University of 
Sao Paulo Medical School. Written consent was obtai-
ned from the patient and their parents.
A 16 year-old Brazilian girl was referred due to ab-
sence of secondary sexual development. She was born 
at 40 weeks of gestation after an uncomplicated preg-
nancy, a single daughter of non consanguineous pa-
rents. At birth, she weighted 3.250 g and measured 52 
cm. Her growth chart showed that she grew at the 50th 
percentile until 9 months of age, at the 75th percentile 
from 9-33 months, and after 3 years of age at > 95th 
percentile. She underwent spontaneous pubarche at 12 
years, without telarche. She presented menarche at 14 
years, after estrogen replacement without adequate 
breast development. At 16  her height was 183 cm, 20 
cm above her target height, with an eunuchoid habitus 
and her BMI was 15 Kg/m2. Puberty evaluation disclo-
sed Tanner II breast development, Tanner V pubic hair 
and normal female external genitalia (Table 1). Basal 
serum hormone data revealed elevated gonadotropins 
(LH= 40 U/L and FSH= 85 U/L), low estrogen le-
vels, normal PRL, GH, IGF1 and IGFBP3 levels.
RESULTS
Cytogenetic analysis showed a 45,X[4]/46,X,der(X)
[46] karyotype (Figure 1). The parents’ karyotypes 
study was normal. FISH analysis revealed an extra copy 
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Table 1. Clinical data before and after hormonal treatment.
Age
(yrs)
Height
(cm)
SD
(height)
Weight
(kg)
Breast
(Tanner)
Pubic hair
(Tanner) Treatment
11.8 174.8 + 3.5 43 I IV Conjugated estrogen 0.625 mg
16.5 183 + 3.5 50 II V
Valerate of estradiol 2 mg
Levonorgestrel 0.25 mg
16.8 183.5 + 3.5 51 II V
Valerate of estradiol 2 mg
Levonorgestrel 0.25 mg
17 NA NA NA II NA
Ethnyl estradiol 70 ug
Ciproterone acetate 4 mg
17.5 184 + 3.6 51 III V
Ethnyl estradiol 70 ug
Ciproterone acetate 4 mg
18 184.2 + 3.7 52 III V
Ethnyl estradiol 35 ug
Ciproterone acetate 2 mg
18.6 184.4 + 3.7 52 III V
Valerate of estradiol 2 mg
Levonorgestrel 0.25 mg
NA = Not available
Figure 1. GTW-banded Karyotype: 46,X,psu idic(X)(pter→ q21::q21→pter).
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Figure 4. Heredogram of the patient with the microsatellite 
study indicating the paternal origin of der(X). The markers 
DXS991 and DXS986 were not informative.
of SHOX and KAL genes and X centromere (Figures 2 
and 3) in the der(X), showing that the der(X) is a psu 
idic(X)(pter→q21::q21→pter). Microsatellite study re-
vealed the paternal origin of psu idic(X)(pter→q21::q21 
→pter) (Figure 4). The markers DXS991 and DXS986 
localize on Xp11.21 and Xq21.1, respectively, were not 
informative. 
DISCUSSION
Recently, it has been reported that SHOX overdosage 
and gonadal estrogen defi ciency leads to tall adult hei-
ght (7,9). These fi ndings suggest that SHOX overdo-
sage in combination with gonadal dysgenesis leads to 
continuous growth since early infancy until late ado-
lescence, since SHOX functions as a repressor for gro-
wth plate fusion, in contrast with skeletal maturing 
effect of estrogens (10).
Here we reported a patient with a 45,X[4]/46,X,psu 
idic(X)(pter→q21::q21→pter)[46] karyotype and go-
Figure 2. FISH analysis indicating triple copies of SHOX gene in 
metaphase chromosome 
Figure 3. FISH analysis indicating DXZ1 probe hybridization to 
centromere (internal signal) and triple copies of KAL gene 
(arrows) in metaphase chromosome. 
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Table 2. Phenotype of SHOX overdosage in female patients.
Age 
(Yrs)
Height
(cm     SD)
HH TurnerStigmas
Breast 
Development 
(after estrogen)
Cytogenetic Data Der(X) Origin Reference
29 172 + 2.9 Present
Mild webbed 
neck
Full 
development
45,X[40]/46,X,der(X)(pter→q13 or  q21::p14→ 
or p21.2→pter[60] Paternal (10)
20 174 + 2 Present Absent Tanner II 46,X,der(X)(pter→q21::p21→pter) NR (8)
20 161.9 + 0.8 Present Absent
Suffi cient 
development
45,X[28]/46,X,psu idic(X)(q28)[72] NR (9)
20 166 + 1.5 Present Absent Normal 46,X,rec(X)dupl(Xp)inv(X)(p11.22q.21.2)[30] Maternal (13)
14 172 + 2 Present
Multiple nevi, 
high arched 
palate 
NR 46,X,der(X)(pter→q21.2::p11.1→pter)[40] NR (7)
20 NR - 1.2 Present Absent NR 45,X[6]/46,X,der(X)(pter q21.1::p22.3 pter)
[12]/46,X,r(X)(p22q13)[2]
Nr (14)
16 183 + 3.5 Present Absent Tanner II 45,X[4]/46,X, psu idic(X)(pter→q21::q21→pter)[46] Paternal Present 
Study
HH: hypergonadotropic hypogonadism; NR: not reported..
nadal dysgenesis, tall stature, no Turner stigmas and 
poor breast development after estrogen replacement. 
The altered X chromosome has a paternal origin, which 
contains a partial Xq deletion, two centromeres and a 
Xp duplication resulting in an extra SHOX gene. 
To date, six female patients with an extra copy of 
SHOX gene in a der(X) were described (Table 2). 
Three of them had tall stature as well as the present 
case. However, three patients present normal height 
despite the extra copy of SHOX associated to estro-
gen deficiency indicating that an extra copy of SHOX 
is not sufficient for the development of tall stature 
(7-10). On the other hand, Kanaka-Gantenbein, 
2004 suggested that SHOX triplication per se may 
induce the tall stature, since their patient presented 
tall stature in the absence of estrogen deficiency 
(15). These controversial reports may be due to the 
fact that the mechanism of SHOX action still re-
mains unclear.
Our patient showed poor breast development af-
ter estrogen treatment. Normally, these patients pre-
sented adequate breast development after estrogen 
treatment (9,10,13). However, Nakamura et al. also 
reported a patient with gonadal dysgenesis and an ex-
tra copy of SHOX who had poor breast development 
after estrogen therapy (8). The reason for the poor 
breast development in these two patients is still unex-
plained. Further studies in similarly affected patients 
will clarify if the absence of breast development despi-
te high-dose estrogen treatment is related to the extra 
copy of SHOX gene.
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